Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Missitzis, I."'
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Scaldaferri, Debora, Piscitelli, E., Pulze, L., Monti, L., Pedrini, E., De Vito, A., Pelucchi, P., Moro, M., Crosti, M., Gritzapis, A., Karnavas, T., Missitzis, I., Zippo, A., Balza, E., Zucchi, I., Reinbold, R., De Eguileor, M., Mortara, D. Noonan1 L., Taramelli, R., Acquati, F.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3660::f3a609098fdc23e3544d31d5a627c5a3
http://hdl.handle.net/11383/2075048
http://hdl.handle.net/11383/2075048
Autor:
Haritos, C. Michaelidou, K. Mavridis, K. Missitzis, I. Ardavanis, A. Griniatsos, J. Scorilas, A.
Novel molecular markers that address the heterogeneity of breast cancer (BC) and provide meaningful prognostic information for BC patients are needed. Kallikrein-related peptidase 6 (KLK6) is aberrantly expressed and functionally implicated in BC and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1166b0a0715f9dbb1640e15e758cc594
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086727
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086727
Objectives: BCL2-like 12 ( BCL2L12) is a new member of the BCL2 gene family that was discovered and cloned by members of our group and found to be expressed in the mammary gland. Many genes of the BCL2 family were found to be implicated in breast car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cdff294e47143b9f9f70b5df7f1cbe0c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088258
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088258
Breast cancer (BC) continues to affect the lives of millions of women worldwide. Several members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) subfamily are involved in tumor progression. Notably, the CEACAM subfamily harbor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7bbb518a96d4c16520b54728425c970e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087991
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087991
Our aim is to develop peptide vaccines that stimulate tumor antigen-specific T-lymphocyte responses against frequently detected cancers. We describe herein a novel HLA-A*0201-restricted epitope, encompassing amino acids 828-836 (residues QIAKGMSYL),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::8fb074ba975938cba338d9c856020768
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004289
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004289
Autor:
Gritzapis, A. D., Baxevanis, C. N., Missitzis, I., Katsanou, E. S., Alexis, Michael N., Yotis, J., Papamichail, M.
Publikováno v:
Breast Cancer Research and Treatment 80:1(Jul2003):1-13
Journal URL: http://www.springerlink.com/content/102860/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1457::66781a6e5c3d549a29a22fab25128a2c
http://helios-eie.ekt.gr/EIE/handle/10442/2979
http://helios-eie.ekt.gr/EIE/handle/10442/2979
HER-2/neu oncoprotein is overexpressed in a variety of human tumors and is associated with aggressive disease. Immunogenic HER-2/neu CTL epitopes have been used as vaccines for the treatment of HER-2/neu positive malignancies with limited success. By
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::eeab3e1612d0c3784ed12cca92ca0045
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3002329
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3002329
Background. Based on phase II data in advanced breast cancer (BC), the fluorouracil, epirubicin, and vinorelbine (FEN) combination was assessed as perioperative chemotherapy, integrated in a multidisciplinary treatment for locally advanced BC. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1d9251f0504e620ea37ee19a725c2fbb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3095503
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3095503
HER-2/neu is an immunogenic protein eliciting both humoral and cellular immune responses in patients with HER-2/neu-positive (+) tumors. Preexisting cytotoxic T lymphocyte (CTL) immunity to HER-2/neu has so far been mainly evaluated in terms of detec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::51d3444a0b81785320737a66e539a566
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004780
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004780